Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12538745 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Gusperimus

Study has passed its completion date and status has not been verified in more than two years.